AUSTIN, Texas -- Emissary Inc. today announced that it will participate in the 2002 Southwest Equity Capital Summit organized by the Capital Network October 2-3 in Richardson, Texas. Steven Mayo, founder and CEO of Emissary, will present the company's plans to streamline drug and medical device research studies with a new Web-based software initiative.
Emissary is an international contract research organization with a team of more than 200 research professionals. Pharmaceutical, medical device and biotechnology companies have relied on Emissary's rigorous, detail-focused clinical trial services since 1995, and the company has distinguished itself as a technology leader in the $8 billion contract clinical research industry. Earlier this year, Emissary launched TeamTrials, a Web-based platform that accelerates information exchange among researchers, study sponsors and patients, delivering significant time and cost savings in comparison to traditional paper-based clinical trials.
- WHO: Steven Mayo, founder and CEO of Emissary
- WHAT: Selected to present at the 2002 Southwest Equity Capital Summit
- WHEN: October 2-3, 2002
- WHERE: Richardson, Texas
About the Southwest Equity Capital Summit
Organized by the Texas Capital Fund, the 2002 Southwest Equity Capital Summit will feature 30 of the most promising companies in Texas and the Southwest presenting their businesses to an audience of more than 400 attendees, including venture capitalists, private equity investors, corporate investors, high net worth individuals and related finance professionals. Presenting companies were chosen by a selection panel composed of executives from premier venture and private equity firms in the Southwest.
About Emissary Inc.
Emissary Inc. is an international contract research organization (CRO) providing clinical trial management services to the pharmaceutical, medical device and biotechnology industries. Emissary's experienced clinical research teams ensure rapid development of life-saving and life-improving medical products by making quality the priority in every clinical trial. The company is at the forefront of the CRO industry's effort to improve the clinical trials process with TeamTrials(R), a comprehensive software initiative that reduces the cost, time and complexity of clinical trials, benefiting patients, investigators and researchers throughout the global clinical research community. Founded in 1995, Emissary maintains headquarters in Austin, TX, with key affiliates located throughout North America and Europe. For more information, visit Emissary's Web site at http://www.emissary.com/ .
Emissary and TeamTrials are registered trademarks of Emissary Inc.